SE7416039L - - Google Patents

Info

Publication number
SE7416039L
SE7416039L SE7416039A SE7416039A SE7416039L SE 7416039 L SE7416039 L SE 7416039L SE 7416039 A SE7416039 A SE 7416039A SE 7416039 A SE7416039 A SE 7416039A SE 7416039 L SE7416039 L SE 7416039L
Authority
SE
Sweden
Prior art keywords
days
dose
daily
estrogen
progestrogen
Prior art date
Application number
SE7416039A
Other languages
English (en)
Other versions
SE441233B (sv
Inventor
U Lachnit-Fixson
A G Pitchford
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE7416039L publication Critical patent/SE7416039L/xx
Publication of SE441233B publication Critical patent/SE441233B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SE7416039A 1973-12-21 1974-12-19 Trestegskombinationspreparat for oral kontraception SE441233B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2365103A DE2365103C3 (de) 1973-12-21 1973-12-21 V erwendung von Hormonen zur Kontrazeption

Publications (2)

Publication Number Publication Date
SE7416039L true SE7416039L (nl) 1975-06-23
SE441233B SE441233B (sv) 1985-09-23

Family

ID=5902211

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7416039A SE441233B (sv) 1973-12-21 1974-12-19 Trestegskombinationspreparat for oral kontraception

Country Status (13)

Country Link
US (1) US3957982A (nl)
BE (1) BE823689A (nl)
CA (1) CA1029303A (nl)
CY (1) CY1065A (nl)
DE (1) DE2365103C3 (nl)
DK (1) DK155308C (nl)
GB (1) GB1490099A (nl)
HK (1) HK47080A (nl)
KE (1) KE3059A (nl)
MY (1) MY8100118A (nl)
NL (1) NL178845C (nl)
SE (1) SE441233B (nl)
ZA (1) ZA748128B (nl)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292315A (en) * 1977-12-30 1981-09-29 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
DE3029726A1 (de) * 1980-08-06 1982-02-25 Werner Dr.med. 4400 Münster Steinschulte Postkoitale kontrazeptiva mit norgestrel oder levonorgestrel
US4425339A (en) 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU582540B2 (en) * 1983-08-05 1989-04-06 Pre Jay Holdings Ltd. A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
DE3347125A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
US4610687A (en) * 1984-08-06 1986-09-09 Board Of Trustees Operating Michigan State University Method for breeding control in female bovines
US5010070A (en) * 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
US4816257A (en) * 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
US4958736A (en) * 1986-03-18 1990-09-25 Gynex, Inc. Package for oral contraceptive tablet
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
DK174724B1 (da) † 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
CA1336328C (en) * 1988-04-11 1995-07-18 Walter G. Leonard Method of increasing bone density in humans
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
KR100501021B1 (ko) * 1996-07-26 2005-07-18 와이어쓰 경구 피임약
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6214815B1 (en) 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US20050038006A1 (en) * 1998-12-23 2005-02-17 Shangold Gary A. Triphasic oral contraceptive
US6660726B2 (en) * 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
EP1622623A4 (en) * 2003-04-11 2009-03-18 Barr Lab Inc METHOD FOR THE ADMINISTRATION OF ESTROGENIC AND TESTED
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
US11376263B2 (en) 2020-10-08 2022-07-05 Fortress Biotech, Inc. Cyproterone acetate compositions and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (nl) * 1966-11-02 1968-05-03
US3568828A (en) * 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3795734A (en) * 1970-04-20 1974-03-05 American Home Prod Cyclic regimen of hormone administration for contraception
US3733407A (en) * 1971-08-25 1973-05-15 Syntex Corp Menopause treatment
DE2310963A1 (de) * 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
DE2335265A1 (de) * 1973-07-09 1975-01-30 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten

Also Published As

Publication number Publication date
DK155308B (da) 1989-03-28
HK47080A (en) 1980-09-05
AU7670874A (en) 1976-06-24
GB1490099A (en) 1977-10-26
CA1029303A (en) 1978-04-11
DK155308C (da) 1989-08-28
ZA748128B (en) 1976-01-28
NL178845B (nl) 1986-01-02
DE2365103C3 (de) 1980-08-28
SE441233B (sv) 1985-09-23
DE2365103A1 (de) 1975-07-10
CY1065A (en) 1980-10-24
US3957982A (en) 1976-05-18
NL7416807A (nl) 1975-06-24
MY8100118A (en) 1981-12-31
DK667674A (nl) 1975-09-08
NL178845C (nl) 1986-06-02
DE2365103B2 (de) 1979-12-20
KE3059A (en) 1980-07-11
BE823689A (fr) 1975-06-20

Similar Documents

Publication Publication Date Title
SE7416039L (nl)
EP0136011A3 (en) A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
GB1459675A (en) Method for the prevention of conception
ES380943A1 (es) Un procedimiento para preparar una composicion anastesica adecuada para administracion parenteral.
GB1291205A (en) A novel pregnane derivative, processes for its preparation, and compositions incorporating it
IL30594A0 (en) New pharmaceutical steroidal compositions,especially useful for treatment of climacteric disorders
SE7607405L (sv) Nya medel och nya sett att behandla klimakteriska besver
ZA744412B (en) Method of contraception by the administration of stage-combination preparations
GB1214712A (en) Contraceptive preparations
GB1231412A (nl)
DK120337B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ<4,6>-steroiddiener af androstan- eller pregnanrækken.
FR1527737A (fr) Nouveau procédé de préparation de la 16alpha, 17alpha-dihydroxy 19-nor progestérone et de ses dérivés de condensation avec des composés carbonylés
ES294897A1 (es) Mejoras introducidas en la preparación de composiciones farmacéuticas en forma de dosis unitarias
JPS5210489A (en) Preparation of 17-esters of pregnane steroids
IL36777A0 (en) A new 2,3-diazabicyclo(5,4,3)-undecapentaene derivative,its preparation and pharmaceutical compositions containing it
ES395365A1 (es) Procedimiento para la obtencion de agentes anticonceptivos.
GB1116795A (en) An oral contraceptive preparation
Crist Post-coital estrogen
JPS52110816A (en) Medicines
ES350825A1 (es) Procedimiento para la preparacion de 2-azidoacetofenonoxima.
GB1183802A (en) Orally Effective Oestrogens
IL36608A (en) 16alpha,17alpha-dihydroxy-21-fluoro-pregna-4,6-diene-3,20-diones and derivatives thereof,their manufacture and pharmaceutical compositions containing them
GB1044997A (en) ª¤-diisopropylaminoethoxybutyrophenone, its hydrochloride and methods for the preparation thereof
JPS51125372A (en) Aprocess for preparing pregnane steroid-17-ester-21-halides
IL36653A0 (en) A new highly active oestrogenic steroid of the estrane series,its manufacture and pharmaceutical compositions containing it

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7416039-1

Effective date: 19950110

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7416039-1

Format of ref document f/p: F